Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 5/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.39 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.39 |
| ▸ | ITGAV | P06756 | 1/20 | 0.39 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | DRD4 | P21917 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | MET | P08581 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12422721 | 0.81 | CYP19A1 (0.36) | SLC6A2SLC6A4SLC6A3ITGB3ITGAV | |
| SCHEMBL15428344 | 0.79 | SLC6A2 (0.37) | SLC6A2SLC6A4SLC6A3ITGB3ITGAV | |
| SCHEMBL12384488 | 0.77 | HDAC1 (0.57) | SLC6A2SLC6A4SLC6A3HDAC1HDAC8 | |
| SCHEMBL6099420 | 0.71 | NPC1 (0.55) | SLC6A2SLC6A4SLC6A3HDAC1HDAC8 | |
| SCHEMBL27742085 | 0.66 | SLC6A2 (0.46) | SLC6A2SLC6A4SLC6A3HDAC1HDAC8 | |
| SCHEMBL3268892 | 0.64 | SIGMAR1 (0.51) | SLC6A4HDAC1HDAC8SIGMAR1KDM1A | |
| SCHEMBL8666600 | 0.64 | HDAC1 (0.55) | HDAC1HDAC8CYP19A1KDM1AMAOA | |
| SCHEMBL13539226 | 0.64 | NPC1 (0.45) | SLC6A2SLC6A4SLC6A3HDAC1HDAC8 | |
| SCHEMBL13230530 | 0.64 | HDAC1 (0.47) | SLC6A2SLC6A4SLC6A3HDAC1HDAC8 | |
| SCHEMBL30030142 | 0.63 | CYP17A1 (0.55) | SLC6A2SLC6A4SLC6A3HDAC1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8633239-B2 | Process for the preparation of eletriptan | BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (IN) | 2014-01-21 | — | — | US | disclosed |
| US-20110207943-A1 | NOVEL PROCESS FOR THE PREPARATION OF ELETRIPTAN | BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (IN) | 2011-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207943-A1 | NOVEL PROCESS FOR THE PREPARATION OF ELETRIPTAN | HTR3C, HTR3A, HTR1A | SLC6A2 152/4885SLC6A4 25/4885SLC6A3 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.